HIGHLIGHTS
- who: TYPE and collaborators from the Henan Provincial People`s Hospital, China University, China have published the research work: LncRNA and its role in gastric cancer immunotherapy, in the Journal: (JOURNAL)
SUMMARY
Apart from common surgeries, including surgical or endoscopic resection, adjuvant and perioperative chemotherapy, immunotherapy, especially immunotherapy checkpoint inhibitors (ICI) therapy, is now established as an essential strategy for chemo refractory GC therapy (Kang et_al, 2017; Wang et_al, 2021a). For the distribution of tumor patients with low, medium, and high load TMB expression, some studies believe that the proportion of low TMB . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.